- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tucatinib plus trastuzumab and pertuzumab
Total 4826 results
-
Hebei Medical UniversityUnknownLiver Metastasis | HER-2 Positive Gastric CancerChina
-
Genentech, Inc.Hoffmann-La RocheRecruitingNeoplasm MetastasisAustralia, Korea, Republic of, China, United States, Portugal, Brazil, Singapore, Spain, United Kingdom, Belgium, Austria, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, France, Germany, Hong Kong, Hungary, Israel, Italy, Japan, Me... and more
-
Otto Metzger, MDGenentech, Inc.Active, not recruitingMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
The Methodist Hospital Research InstituteNovartis; Celgene CorporationCompletedBreast CancerUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Breast Adenocarcinoma | Inflammatory Breast CarcinomaUnited States
-
Fudan UniversityHoffmann-La RocheUnknown
-
Spanish Breast Cancer Research GroupCompleted
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; TakedaNot yet recruiting
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
University Medical Center GroningenCompleted
-
Nantes University HospitalChugai Pharmaceutical; French Innovative Leukemia OrganisationCompleted
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
The Greater Poland Cancer CentreActive, not recruiting
-
Hoffmann-La RocheLatin American Cooperative Oncology GroupActive, not recruitingBreast CancerColombia, Guatemala, Argentina, Brazil, Chile, Cuba, Mexico, Peru, Uruguay, Dominican Republic
-
Hoffmann-La RocheCompleted
-
Orano Med LLCCompletedStomach Neoplasms | Breast Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms | Peritoneal NeoplasmsUnited States
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
BiogenCompleted
-
Seagen Inc.CompletedHepatic ImpairmentUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedT-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsSarcoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsCompletedAcute Lymphoblastic Leukemia (ALL)United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
-
Peking University Cancer Hospital & InstituteNot yet recruiting
-
Yale UniversityGenentech, Inc.WithdrawnPaget's Disease of the VulvaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La RocheRecruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
PfizerCompleted
-
UCB Biopharma S.P.R.L.Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaboratorsCompletedSystemic Lupus ErythematosusUnited Kingdom
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
UCB PharmaTerminatedLupus Erythematosus, SystemicUnited States
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, Belgium, Netherlands, United Kingdom, Spain, Hungary
-
Seagen Inc.Completed
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Providence Health & ServicesSeagen Inc.WithdrawnBreast Cancer Stage IVUnited States
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast NeoplasmsItaly, Netherlands, Belgium, United Kingdom, Argentina, Austria, Brazil, China, Ecuador, Estonia, Finland, France, Germany, Greece, Mexico, Peru, Poland, Portugal, Slovenia, Spain, United Arab Emirates, Canada, Hungary, Israel, Sweden, Tu... and more
-
Fudan UniversityActive, not recruiting
-
M.D. Anderson Cancer CenterCompletedDuctal Carcinoma In SituUnited States
-
Hoffmann-La RocheTerminatedUrinary Tract CancerGermany